Google introduces new features for its Pixel Watch 5 that claim to monitor blood pressure without a cuff and to estimate insulin resistance. The additions position the watch as a health-tracking device aimed at identifying potential metabolic risk.
Both outlets describe the insulin resistance tracking as a way to support early detection of elevated diabetes risk. The Independent and Engadget both attribute the concept to Google’s framing of the tools as an early warning system, suggesting they may help flag changes that could warrant follow-up with healthcare professionals. While details such as how measurements work, their accuracy, and whether results are available through specific apps or regions are not covered in the provided excerpts, the sources align that the watch adds both cardiovascular and diabetes-risk related metrics.
Engadget emphasizes the combined set of functions—blood pressure monitoring and insulin resistance estimation—while The Independent highlights that blood pressure tracking is designed to be performed without a cuff and also notes the insulin resistance link to type 2 diabetes risk. Both articles therefore focus on the health-monitoring expansion rather than on clinical validation or deployment timelines.
